ALPHA TRIBE

3B BlackBio Dx LtdBoard Meeting, 13-11-2025: Board Meeting

13-11-2025 | 04:59 pm

3B BlackBio Dx's board approved Q2 & H1 FY26 financials. Consolidated Q2 revenue: ₹33.9 Cr, profit: ₹15.04 Cr. H1 revenue: ₹56.74 Cr, profit: ₹27.68 Cr. Figures incorporate Coris Holding SRL acquisition from late Aug. Agrochemicals are seasonal.

No comments yet. Be the first to comment!

All announcements from 3B BlackBio Dx Ltd